Converge Bio has raised $5.5 million in seed funding led by TLV Partners.WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs…
The first patient in England has been treated with a personalised vaccine against bowel cancer, in a clinical trial as part of NHS England’s Cancer Vaccine Launch Pad.The launch pad, created in partnership with…
Continue Reading
Margaret Anderson, Managing Director at Deloitte Consulting LLP
In response to the COVID-19 pandemic, the biomedical community took on the task of developing and deploying critical interventions to address an unprecedented public health emergency. In…
Continue Reading
Researchers at MIT have developed an enhanced mRNA vaccine system that can elicit a greater immune response at lower doses. The vaccine technology is so potent that it may be useful for intranasal COVID-19…
Continue Reading
Researchers at the Mount Sinai Hospital have developed an mRNA-based treatment for cancer. The approach combines the delivery of mRNA therapy in lipid nanoparticles and also involves co-delivering dendritic cells that have also been…
Continue Reading
A partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and biotech company aVaxziPen, is hoping to improve access to vaccines by removing the need for frozen storage. CEPI will initially provide up to $1.6million…
Continue Reading
For many of the most severe health conditions, early detection greatly increases the chance of successful treatment and much better outcomes. This article shows how some surprising technologies are improving the early detection of…
Continue Reading
Researchers at MIT have developed a printer that can create large numbers of microneedle patch-style vaccines in places where they are needed quickly. Moreover, the printed patches can deliver thermostable mRNA vaccines, whereby the…
Continue Reading
The CDC has reported that the monovalent mRNA vaccine is 76% effective at preventing COVID-19-related invasive mechanical ventilation and death up to 6 months after the last dose, and 56% effective for at least…
Continue Reading
By Shania Kennedy April 25, 2023 – Moderna and IBM announced a partnership to leverage novel technologies, such as artificial intelligence (AI) and quantum computing, to accelerate messenger RNA (mRNA) research.
Quantum computing is a subset…
